Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child

scientific article published on 25 June 2002

Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1019449968
P356DOI10.1007/S00431-002-0981-1
P698PubMed publication ID12172829

P2093author name stringAndreas Sauerbrei
Stefan Burdach
Gerd Horneff
Barbara Uebe
P433issue8
P921main subjectherpes zosterQ182155
P304page(s)442-444
P577publication date2002-06-25
P1433published inEuropean Journal of PediatricsQ15755736
P1476titleHerpes zoster by reactivated vaccine varicella zoster virus in a healthy child
P478volume161

Reverse relations

cites work (P2860)
Q33774777A case of optic neuritis complicating herpes zoster ophthalmicus in a child
Q38731791Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections
Q34027426Emerging drugs for varicella-zoster virus infections
Q37702470Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster
Q40330700Genotype analysis of ORF 62 identifies varicella-zoster virus infections caused by a vaccine strain in children
Q46084635Herpes zoster keratouveitis and inflammatory ocular hypertension 8 years after varicella vaccination
Q35979111Herpes zoster ophthalmicus in an otherwise healthy 2-year-old child
Q38547930Herpes zoster ophthalmicus: declining age at presentation
Q53859755Molecular diagnosis of zoster post varicella vaccination.
Q39632682Monitoring prevalence of varicella-zoster virus clades in Germany
Q35047428Necrotizing fasciitis and streptococcal toxic shock syndrome secondary to varicella in a healthy child
Q26863614Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data
Q40150603Role of the JNK Pathway in Varicella-Zoster Virus Lytic Infection and Reactivation
Q34590637Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005.
Q35666726Sero-Prevalence of Antibodies against Varicella Zoster Virus in Children under Seven-Years Old in 2012 in Tehran, Iran
Q33900399The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA.
Q38264045Varicella zoster virus vaccines: potential complications and possible improvements

Search more.